HDAX have been selected for the Emerging Companies Forum at the 18th Annual BIOTECanada Investor Summit
![adMare](/cmc/sites/files/cmc/styles/full_width_m/public/shared/adMare.jpg.webp?itok=PCQu-Ymm)
HDAX Therapeutics receives top prize $25,000 at the University of Toronto Entrepreneurship Week Startup pitch competition
![HDAX Team](/cmc/sites/files/cmc/styles/full_width_m/public/shared/HDAX-Team-Photo-768x431.png.webp?itok=NHgZKLYS)
HDAX Therapeutics, a trainee-led team out of the lab of professor Patrick T. Gunning, Department of Chemical & Physical Sciences, University of Toronto Mississauga, took home the top prize of $25,000 in the later-stage category of the UTE Startup Prize pitch competition, part of U of T’s annual Entrepreneurship Week event. Clockwise from top left: Pimyupa Manaswiyoungkul, bioassay specialist; Nabanita Nawar, medicinal chemist and PhD candidate; Tobi Olaoye, chemical biologist and PhD candidate; and Elvin de Araujo, research manager, Center for Medicinal Chemistry.
Sign up to receive the latest news and updates.